AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 OCT 11 - (NewsRx.com & NewsRx.net) --
by Michael Greer, senior medical writer - A system for the ex vivo expansion of bone marrow can be used to improve the likelihood of stem cell engraftment after transplantation, researchers in the United States report.
"To reduce the number of apheresis procedures and maintain the usual rate of hematopoietic recovery in patients treated with high-dose chemotherapy, we studied the effect of adding a small volume of ex vivo expanded bone marrow to low doses of CD34(+) blood stem cells," explained Dr. A.L. Pecora and colleagues at the Hackensack University Medical Center and Progenitor Cell Therapy, L.L.C., in Hackensack, New Jersey; Loyola University in Maywood, Illinois; the Southwest Texas Cancer Institute in San Antonio; and Aastrom Biosciences in Ann Arbor, Michigan.
Pecora and coworkers found that expanded bone marrow could reduce stem cell collection requirements and increase the chances of successful transplantation.
A group of 34 breast cancer patients were treated with low-dose autologous stem cell infusions, supplemented with filgrastim and with bone marrow expanded using the AastromReplicell system. No patient required more than one apheresis session for stem cell harvesting, the researchers noted.
The researchers observed a significant correlation between the amount of stromal progenitor cells in expanded bone marrow infusions and the likelihood of successful stem cell engraftment (p=0.004). The only other variable linked to successful transplantation was the amount of lineage-negative ...